Category Archives: News

Lung Cancer Europe is growing stronger

Starting September, Alfonso Aguarón (second from left) is LuCE’s new project manager. He has extensive experience in patient advocacy field as Hodgkin’s Lymphoma survivor. This circumstance led him to get involved in patient advocacy, first on a volunteer basis and later on, becoming fully involved on a professional basis in 2009. He was involved in Spanish patient groups of haematology […]

Read More

New ESMO tumour DNA scale helps match patients with cancer to optimal targeted medicines

A new scale for tumour DNA mutations which will simplify and standardise choices for targeted cancer treatment has been agreed by leading cancer specialists in Europe and North America. The scale, called ESCAT (ESMO Scale for Clinical Actionability of molecular Targets), is published this week in the Annals of Oncology. It aims to optimise patient care by making it easier to […]

Read More

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of NSCLC

Due to the distinct features of cancer immunotherapy, and rapid progress in the field, clinical guidance is needed on the use of these agents, including appropriate patient selection, sequencing of therapies, response monitoring, adverse event management, and biomarker testing. The Society for Immunotherapy of Cancer (SITC) convened an expert Task Force charged with developing consensus recommendations on these key issues. […]

Read More

IASLC issues statement paper on liquid biopsy for lung cancer

The lungs can be a difficult organ to biopsy with a needle, so the promise of identifying lung cancer through a blood-based biopsy has lung cancer experts and patients optimistic. Knowing how and when to use a liquid biopsy is critically important and led global experts at the International Association for the Study of Lung Cancer (IASLC) to issue “The […]

Read More